Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039483 (
giant cell arteritis
)
3,204
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of the present study was to investigate the expression of TP53 (p53) and CDKN1A (CIP1;
p21
) in the arterial wall in
giant cell arteritis
(
GCA
). Cross-sections from 18 temporal artery biopsies displaying
GCA
and 8 control arteries were double-stained with monoclonal antibody directed at p53 or
p21
on the one hand and alpha-smooth muscle actin, CD68 (macrophage) or CD3 (T-cell) on the other. Nuclear p53 was expressed in CD68-positive cells and smooth muscle cells in 16 of the 18 inflamed arteries. P21-positive nuclei were found in CD68-positive cells in 14 biopsies and in smooth muscle cells in all the specimens. All p53-positive giant cells also contained
p21
-positive nuclei. In the giant cells, immunopositive nuclei were mixed with negative ones. CD3-positive T-cells did not express p53 or
p21
. Only one p53-positive smooth muscle cell nucleus was found in the non-
GCA
controls and, compared with
GCA
,
p21
expression was noted in few smooth muscle nuclei. The presence of p53 and
p21
in the same types of cell in
GCA
indicates that the former protein is functional;
p21
expression is induced by wild-type, functional p53 but not by its mutant form. The current observations suggest cellular stress in
GCA
, the nature of which requires further investigation.
...
PMID:Cell-type-specific expression of p53 and p21 in giant cell arteritis. 1621 34